The All of Us Research Program is a key element of the Precision Medicine Initiative. Two years on, we take a look at what they have achieved, and how they plan on integrating their research into the U.S. healthcare system over the next ten years.
New research suggests that the level of testosterone in an adult man is largely determined by the stress they encounter during their childhood, challenging the idea that testosterone production is controlled by genetics.
Researchers have conducted the first demonstration of site-specific gene editing in a mouse fetus, correcting a mutation that causes a severe form of anaemia.
Researchers have created nanoparticles that can zap tumours with significant amounts of heat under a low magnetic field.
By analysing more than 125 existing datasets, researchers have revealed that DIP-seq, one of the most widely used methods in epigenetics research, commonly detected DNA sequences that did not have any epigenetic marks.
Our faces can reveal a lot about us, and now scientists are revealing a lot about faces. Research into the genetics that shapes the face has made tremendous advances in recent years.
The U.S. Food and Drug Administration has approved the first drug derived from Marijuana to treat two rare and severe forms of epilepsy. Will the U.K. follow?
A report has highlighted the potential misuses of synthetic biology for biological warfare with recommendations of how we might prepare for and prevent biological attacks.
There’s no therapy developed yet, that can stop cancer cells from moving throughout the body. New research shows that it may be possible to do so, in freezing cancer cells and killing them where they stand.
Scientists seeking to unlock secrets of cellular ageing have identified a gene that triggers senescence, a phenomenon in which cells stop dividing.
Psychiatric disorders share many genetic variants, while neurological disorders appear more distinct, according to a new study from the Brainstorm Consortium.